Internal Medicine, Cardiovascular Disease · Anaheim, CA
NPI
1164483244
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1712 W Medical Center Dr
Anaheim, CA, 92801
Phone (714) 491-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
15,095 services
Medicare patients, 2024
935
Average age 76
Drug cost, 2024
$4.7M
14,536 prescriptions
Company payments, 2025
$19K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raveen R Arora was code 99214 (office e&m - established), 2,336 times for 672 patients. In total Raveen R Arora billed 15,095 services in 118 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,336 | 672 | $109.71 | $256K |
| 99232 Hospital E&M - Subsequent | Facility | 2,070 | 195 | $66.75 | $138K |
| 99458 E&M - Miscellaneous | Office | 1,533 | 269 | $30.54 | $47K |
| 99457 E&M - Miscellaneous | Office | 1,168 | 312 | $37.79 | $44K |
| 93000 Electrocardiogram | Office | 1,017 | 697 | $11.95 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 888 | 210 | $37.28 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 780 | 403 | $14.08 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 619 | 553 | $178.44 | $110K |
| 99454 E&M - Miscellaneous | Office | 574 | 177 | $36.76 | $21K |
| 71046 X-ray - Chest | Office | 403 | 363 | $30.51 | $12K |
| 99223 Hospital E&M - Initial | Facility | 349 | 236 | $146.45 | $51K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 334 | 328 | $174.78 | $58K |
| 99215 Office E&M - Established | Office | 305 | 226 | $150.29 | $46K |
| 93228 Electrocardiogram | Office | 267 | 249 | $21.30 | $5,688 |
| 93229 Electrocardiogram | Office | 267 | 249 | $772.46 | $206K |
By year: 2022 $1.1M for 14,393 services; 2023 $1.4M for 18,725 services; 2024 $1.2M for 15,095 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 15 | 14 | $3.41 | $51.15 |
Medicare prescription drug claims, 2024
In 2024, the drug Raveen R Arora prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 997 prescriptions and refills. In total Raveen R Arora wrote 14,536 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 997 | 1,209 | 170 | $622K |
| Atorvastatin Calcium Generic | 954 | 2,590 | 284 | $9,400 |
| Vascepa Icosapent Ethyl | 712 | 1,161 | 154 | $382K |
| Carvedilol Generic | 613 | 1,534 | 160 | $5,493 |
| Amlodipine Besylate Generic | 597 | 1,551 | 175 | $3,578 |
| Losartan Potassium Generic | 473 | 1,214 | 137 | $4,231 |
| Eliquis Apixaban | 473 | 875 | 114 | $490K |
| Nebivolol Hcl Generic | 448 | 1,042 | 128 | $24K |
| Edarbi Azilsartan Medoxomil | 406 | 947 | 105 | $216K |
| Entresto Sacubitril/Valsartan | 404 | 756 | 85 | $477K |
| Praluent Pen Alirocumab | 399 | 532 | 73 | $230K |
| Mounjaro Tirzepatide | 398 | 438 | 63 | $446K |
| Icosapent Ethyl Generic | 380 | 671 | 114 | $91K |
| Farxiga Dapagliflozin Propanediol | 348 | 605 | 76 | $332K |
| Ozempic Semaglutide | 321 | 378 | 56 | $341K |
Brand drugs: 5,748 claims; generic drugs: 8,759 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raveen R Arora $19K ($19K in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $9,347.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 26 | $9,347 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $6,425 |
| Heartflow, Inc. HTFL | 4 | $597 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $513 |
| Abiomed JNJ | 4 | $371 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $338 |
| Novo Nordisk Inc NVO | 11 | $293 |
| Alnylam Pharmaceuticals Inc. ALNY | 5 | $248 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $234 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $225 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.